Study Details

BluePearl Specialty and Emergency Pet Hospital is participating in a fully funded, placebo-controlled, randomized study to confirm the efficacy and safety of verdinexor for the treatment of lymphoma in dogs. Dogs will randomly be assigned either a placebo or study drug, with a 1 in 5 chance of receiving the study drug. Owners will be required to bring their dog to the hospital for a total of eight visits over 56 days.

Inclusion Criteria

Exclusion Criteria

Duration of study

Enrollment period consists of 56 days.

Covered Costs

The study sponsor will cover all costs for procedures and treatments required by the study.

Pennsylvania – Pittsburgh Participation Contact Rebecca Newman at 412.366.3400.